Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* patients with confirmed sars-cov2 infection who were not primarily admitted for covid-19 pneumonia * patients with use of intranasal sprays for at least two weeks prior to study enrollment * sinonasal surgery within 3 months prior to study enrollment * patients with sinusitis * inability to perform nasopharyngeal wash * participation in other trials	* patients with confirmed sars-cov2 infection who were not primarily admitted for covid-19 pneumonia * patients with use of intranasal sprays for at least two weeks prior to study enrollment * sinonasal surgery within 3 months prior to study enrollment * patients with sinusitis * inability to perform nasopharyngeal wash * participation in other trials
Sept. 3, 2022, 10 p.m.	usa	patients with confirmed sars-cov2 infection who were not primarily admitted for covid-19 pneumonia patients with use of intranasal sprays for at least two weeks prior to study enrollment sinonasal surgery within 3 months prior to study enrollment patients with sinusitis inability to perform nasopharyngeal wash participation in other trials	patients with confirmed sars-cov2 infection who were not primarily admitted for covid-19 pneumonia patients with use of intranasal sprays for at least two weeks prior to study enrollment sinonasal surgery within 3 months prior to study enrollment patients with sinusitis inability to perform nasopharyngeal wash participation in other trials